Haemonetics
(NYSE) HAE
Haemonetics Financials at a Glance
Market Cap
$2.51B
Revenue (TTM)
$1.32B
Net Income (TTM)
$175.44M
EPS (TTM)
$3.64
P/E Ratio
14.85
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$53.98
Volume
1,596,775.949
Open
$55.28
Price
$53.98
Volume
1,596,775.949
Open
$55.28
Previous Close
$54.04
Daily Range
$53.88 - $55.53
52-Week Range
$47.31 - $87.32
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$53.98
Volume
1,596,775.949
Open
$55.28
Previous Close
$54.04
Daily Range
$53.88 - $55.53
52-Week Range
$47.31 - $87.32
HAE News
HAE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Haemonetics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
3,023
CEO
Christopher A. Simon, MBA
Website
www.haemonetics.comHeadquarters
Boston, MA 02110, US
HAE Financials
Key Financial Metrics (TTM)
Gross Margin
58%
Operating Margin
19%
Net Income Margin
13%
Return on Equity
19%
Return on Capital
13%
Return on Assets
7%
Earnings Yield
6.73%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.51B
Shares Outstanding
46.47M
Volume
1.60M
Short Interest
0.00%
Avg. Volume
868.40K
Financials (TTM)
Gross Profit
$778.55M
Operating Income
$221.82M
EBITDA
$355.99M
Operating Cash Flow
$181.72M
Capital Expenditure
$39.28M
Free Cash Flow
$142.45M
Cash & ST Invst.
$306.76M
Total Debt
$1.22B
Haemonetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$338.97M
-2.7%
Gross Profit
$191.41M
-4.3%
Gross Margin
56.47%
N/A
Market Cap
$2.51B
N/A
Market Cap/Employee
$686.71K
N/A
Employees
3,657
N/A
Net Income
$44.74M
+19.3%
EBITDA
$95.48M
+0.4%
Quarterly Fundamentals
Net Cash
$861.37M
+4.7%
Accounts Receivable
$195.71M
-7.7%
Inventory
$321.19M
-10.7%
Long Term Debt
$919.99M
-24.6%
Short Term Debt
$304.75M
+5904.8%
Return on Assets
7.04%
N/A
Return on Invested Capital
12.98%
N/A
Free Cash Flow
$87.22M
+147.6%
Operating Cash Flow
$93.56M
+113.8%